MedTrace Logo

Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance

NCT05575180 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-03-12

No results posted yet for this study

Summary

A single-centered randomized doubled blinded placebo-controlled cross-over trial comparing two the effect of two carbonic anhydrase inhibitors on exercise performance in acute hypoxia. Participants will be young (under 40 years of age), healthy males and females who are regularly physically active.

Conditions

  • High Altitude Effects

Interventions

DRUG

Acetazolamide 250Mg Tab

Oral acetazolamide

DRUG

Methazolamide Pill

Oral Methazolamide

DRUG

Placebo

Oral placebo

Sponsors & Collaborators

  • Wilderness Medical Society

    collaborator UNKNOWN

  • University of Waterloo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-11
Primary Completion
2024-02-22
Completion
2024-02-22

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05575180 on ClinicalTrials.gov